Mitsui looking at raising Arch stake but no done deal yet
This article was originally published in Scrip
The major Japanese trading conglomerate Mitsui & Co has played down reports that it has agreed to increase its holding in India's Arch Pharmalabs, although it confirmed to Scrip that discussions are underway on a possible raising of its investment in the Mumbai-based manufacturing firm.
You may also be interested in...
Product review report reveals multiple delays and missteps on route to market, holding valuable lessons for other gene therapy developers but also evidencing an ultimately welcoming environment.
Join us for a quick audio roundup of major developments in the international biopharma industry over the past week, as covered by Scrip's global team.
Positive clinical results pave path forward for Japanese firm’s potential istradefylline successor.